rs9358531
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000561912.3(CASC15):n.570-7426T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.328 in 152,002 control chromosomes in the GnomAD database, including 9,517 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.33 ( 9517 hom., cov: 31)
Consequence
CASC15
ENST00000561912.3 intron
ENST00000561912.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0460
Genes affected
CASC15 (HGNC:28245): (cancer susceptibility 15) This gene produces a long non-coding RNA that may regulate cell proliferation. This RNA is upregulated in hepatocellular carcinoma, where it is thought to function as an oncogene. However, some splice variants of this gene may function as a tumor suppressor in neuroblastoma and other tumor types. Circular RNA variants were observed at this gene. [provided by RefSeq, Dec 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.422 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|
Ensembl
Frequencies
GnomAD3 genomes AF: 0.328 AC: 49848AN: 151884Hom.: 9521 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
49848
AN:
151884
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.328 AC: 49853AN: 152002Hom.: 9517 Cov.: 31 AF XY: 0.328 AC XY: 24371AN XY: 74288 show subpopulations
GnomAD4 genome
AF:
AC:
49853
AN:
152002
Hom.:
Cov.:
31
AF XY:
AC XY:
24371
AN XY:
74288
Gnomad4 AFR
AF:
AC:
0.135519
AN:
0.135519
Gnomad4 AMR
AF:
AC:
0.338507
AN:
0.338507
Gnomad4 ASJ
AF:
AC:
0.423832
AN:
0.423832
Gnomad4 EAS
AF:
AC:
0.383165
AN:
0.383165
Gnomad4 SAS
AF:
AC:
0.272973
AN:
0.272973
Gnomad4 FIN
AF:
AC:
0.393236
AN:
0.393236
Gnomad4 NFE
AF:
AC:
0.425959
AN:
0.425959
Gnomad4 OTH
AF:
AC:
0.368596
AN:
0.368596
Heterozygous variant carriers
0
1581
3163
4744
6326
7907
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
490
980
1470
1960
2450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1002
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at